Covered recipient · General Payments record
LOREDANA RAMMAGE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,255.87
- Reported across 164 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.75 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $232.13 | 16 |
| Biogen, Inc. | $67.61 | 3 |
| PFIZER INC. | $38.99 | 2 |
| Neurocrine BioSciences, Inc. | $38.85 | 1 |
| Otsuka America Pharmaceutical, Inc. | $37.38 | 2 |
| Aucta Pharmaceuticals, Inc. | $29.98 | 1 |
| Teva Pharmaceuticals USA, Inc. | $24.38 | 1 |
| EMD Serono, Inc. | $22.25 | 1 |
| EISAI INC. | $20.77 | 1 |
| SK Life Science, Inc. | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.27 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366837 | CMS |
| ABBVIE INC. | $33.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366841 | CMS |
| ABBVIE INC. | $21.47 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366845 | CMS |
| ABBVIE INC. | $5.71 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366849 | CMS |
| ABBVIE INC. | $4.79 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366853 | CMS |
| ABBVIE INC. | $14.92 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366857 | CMS |
| ABBVIE INC. | $14.32 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366861 | CMS |
| ABBVIE INC. | $9.81 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366865 | CMS |
| ABBVIE INC. | $9.48 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366869 | CMS |
| ABBVIE INC. | $12.56 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366873 | CMS |
| ABBVIE INC. | $10.30 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366877 | CMS |
| ABBVIE INC. | $2.63 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366881 | CMS |
| ABBVIE INC. | $12.63 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366886 | CMS |
| ABBVIE INC. | $21.05 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366890 | CMS |
| ABBVIE INC. | $4.42 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366894 | CMS |
| ABBVIE INC. | $22.24 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366898 | CMS |
| Aucta Pharmaceuticals, Inc. | $29.98 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147904884 | CMS |
| Biogen, Inc. | $19.89 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104853450 | CMS |
| Biogen, Inc. | $22.39 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872910 | CMS |
| Biogen, Inc. | $25.33 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831432 | CMS |
| Eisai Inc. | $20.77 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110760920 | CMS |
| EMD Serono, Inc. | $22.25 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245331 | CMS |
| Neurocrine Biosciences, Inc. | $38.85 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150815764 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.97 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118966463 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.41 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118966465 | CMS |
| PFIZER INC. | $20.40 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131803619 | CMS |
| PFIZER INC. | $18.59 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131802123 | CMS |
| SK Life Science, Inc. | $13.41 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154121057 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.38 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151704211 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.